Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 471-480 of 1154 total displayed.

Past content (since Jan 1999):

Articles
Xuezhikang, an Extract of Cholestin, Protects Endothelial Function Through Antiinflammatory and Lipid-Lowering Mechanisms in Patients With Coronary Heart Disease
Shui Ping Zhao, Ling Liu, Yan Chun Cheng, Mehdi H. Shishehbor, Ming Hui Liu, Dao Quan Peng, and Yu Ling Li
Circulation published August 16, 2004, doi:10.1161/01.CIR.0000139985.81163.CE [Abstract]  

Correspondence
Potential Statin–Clopidogrel Interaction Requires More Study Response
David Williams, Isobel Ford, Gabrielle Hawksworth, John V. Mitsios, Athanasios I. Papathanasiou, Foteini I. Rodis, Moses Elisaf, John A. Goudevenos, and Alexandros D. Tselepis
Circulation 2004;110:e68, doi:10.1161/01.CIR.0000137952.17943.5A [Full text]  

Congenital Heart Disease
Outcomes in Children With Idiopathic Pulmonary Arterial Hypertension
Delphine Yung, Allison C. Widlitz, Erika Berman Rosenzweig, Diane Kerstein, Greg Maislin, and Robyn J. Barst
Circulation 2004;110:660-665; published online before print as doi:10.1161/01.CIR.0000138104.83366.E9 [Abstract] [Full text]  

Heart Failure
Celiprolol, A Vasodilatory ß-Blocker, Inhibits Pressure Overload–Induced Cardiac Hypertrophy and Prevents the Transition to Heart Failure via Nitric Oxide–Dependent Mechanisms in Mice
Yulin Liao, Masanori Asakura, Seiji Takashima, Akiko Ogai, Yoshihiro Asano, Yasunori Shintani, Tetsuo Minamino, Hiroshi Asanuma, Shoji Sanada, Jiyoong Kim, Soichiro Kitamura, Hitonobu Tomoike, Masatsugu Hori, and Masafumi Kitakaze
Circulation 2004;110:692-699; published online before print as doi:10.1161/01.CIR.0000137831.08683.E1 [Abstract] [Full text]  

Articles
Randomized, Double-Blind, Placebo-Controlled Trial of Oral Sirolimus for Restenosis Prevention in Patients With In-Stent Restenosis. The Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) Trial
Jörg Hausleiter, Adnan Kastrati, Julinda Mehilli, Michael Vogeser, Dietlind Zohlnhöfer, Helmut Schühlen, Christoph Goos, Jürgen Pache, Franz Dotzer, Gisela Pogatsa-Murray, Josef Dirschinger, Uwe Heemann, Albert Schömig for the OSIRIS Investigators
Circulation published August 9, 2004, doi:10.1161/01.CIR.0000138935.17503.35 [Abstract]  

Hypertension
Different Effects of Antihypertensive Therapies Based on Losartan or Atenolol on Ultrasound and Biochemical Markers of Myocardial Fibrosis: Results of a Randomized Trial
Michele M. Ciulla, Roberta Paliotti, Arturo Esposito, Javier Dìez, Begoña López, Björn Dahlöf, M. Gary Nicholls, Ronald D. Smith, Leen Gilles, Fabio Magrini, and Alberto Zanchetti
Circulation 2004;110:552-557; published online before print as doi:10.1161/01.CIR.0000137118.47943.5C [Abstract] [Full text]  

Articles
Outcomes in Children With Idiopathic Pulmonary Arterial Hypertension
Delphine Yung, Allison C. Widlitz, Erika Berman Rosenzweig, Diane Kerstein, Greg Maislin, and Robyn J. Barst
Circulation published August 2, 2004, doi:10.1161/01.CIR.0000138104.83366.E9 [Abstract]  

Coronary Heart Disease
Anti-Xa Activity Relates to Survival and Efficacy in Unselected Acute Coronary Syndrome Patients Treated With Enoxaparin
G. Montalescot, J.P. Collet, M.L. Tanguy, A. Ankri, L. Payot, R. Dumaine, R. Choussat, F. Beygui, V. Gallois, and D. Thomas
Circulation 2004;110:392-398; published online before print as doi:10.1161/01.CIR.0000136830.65073.C7 [Abstract] [Full text]  

Heart Failure
Adrenomedullin Administration Immediately After Myocardial Infarction Ameliorates Progression of Heart Failure in Rats
Ryosai Nakamura, Johji Kato, Kazuo Kitamura, Hisamitsu Onitsuka, Takuroh Imamura, Yuanning Cao, Kousuke Marutsuka, Yujiro Asada, Kenji Kangawa, and Tanenao Eto
Circulation 2004;110:426-431; published online before print as doi:10.1161/01.CIR.0000136085.34185.83 [Abstract] [Full text]  

Articles
Different Effects of Antihypertensive Therapies Based on Losartan or Atenolol on Ultrasound and Biochemical Markers of Myocardial Fibrosis. Results of a Randomized Trial
Michele M. Ciulla, Roberta Paliotti, Arturo Esposito, Javier Dìez, Begoña López, Björn Dahlöf, M. Gary Nicholls, Ronald D. Smith, Leen Gilles, Fabio Magrini, and Alberto Zanchetti
Circulation published July 26, 2004, doi:10.1161/01.CIR.0000137118.47943.5C [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment